Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report
Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Sanofi Genzyme (Genzyme), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, Mozobil injection, Taxotere injection concentrate, Thymoglobulin, Thyrogen and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. Genzyme is headquartered in Cambridge, Massachusetts, the US.
- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments
- Intelligence on Sanofi Genzyme's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sanofi Genzyme's business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 5
Sanofi Genzyme: Company Overview 9
Sanofi Genzyme: Overview and Key Facts 9
Sanofi Genzyme: Overview 9
Sanofi Genzyme: Key Facts 9
Sanofi Genzyme: Key Employees 10
Sanofi Genzyme: Key Employee Biographies 12
Sanofi Genzyme: Major Products and Services 14
Sanofi Genzyme: Company History 15
Sanofi Genzyme: Locations and Subsidiaries 21
Sanofi Genzyme: Key Competitors 22
Sanofi Genzyme: Company Analysis 23
Sanofi Genzyme: Business Description 23
Sanofi Genzyme: SWOT Analysis 25
Sanofi Genzyme: SWOT Overview 25
Sanofi Genzyme: Strengths 25
Sanofi Genzyme: Weaknesses 26
Sanofi Genzyme: Opportunities 26
Sanofi Genzyme: Threats 27
Sanofi Genzyme: Corporate Financial Deals Activity 28
Sanofi Genzyme: Financial Deals Overview 28
Sanofi Genzyme: Targets and Partners 29
Sanofi Genzyme: Top Deals 2014-2018YTD 30
Sanofi Genzyme: Mergers and Acquisitions 31
Sanofi Genzyme: Partnership 32
Sanofi Genzyme: Recent Developments 33
Sanofi Genzyme: News and Events Summary 33
Sanofi Genzyme: Contracts 36
Sanofi Genzyme: Market Developments 36
Sanofi Genzyme: Regulatory and Legal Events 38
Sanofi Genzyme: Research & Development 39
Sanofi Genzyme: Strategy and Operations 40
Contact Us 41
About MarketLine 42
List of Figures
Figure 1: Sanofi Genzyme: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Figure 2: Sanofi Genzyme: M&A Average Deal Size-Value (USD m)
Figure 3: Sanofi Genzyme: M&A Volume and Value Trend (2014-YTD 2018)
Figure 4: Sanofi Genzyme: Partnership Volume and Value Trend (2014-YTD 2018)
Figure 5: San
Single User License:
Corporate User License:
select a license
NEWSLETTER BY CATEGORY
An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ... "General Manager SBU Manufacture, PT. KIMIA FARMA, TBK"
Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process.... "VP Innovation, Engineered Profiles LLC"
Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed... "President, VPP E-Data Services, VPP E-Data Services"
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"